The maker of Viagra, Lipitor and Advil has been slashing thousands of jobs since acquiring rival Wyeth in 2009.
Now, as several of its key products run out of patent protection, it is also downsizing its research and development spending.
The company plans to still cut another 5,530 employees -- or 5% of its global workforce. While many of those jobs cuts will come from the closure of a factory in Sandwich, England, they will also affect many U.S. employees who work in R&D roles.
These young job seekers graduated into the worst labor market since the Great Depression.
|Charles Osgood announces Jane Pauley as his successor|
|The life and crimes of Sin City's million-dollar mail fraudster|
|Say hello to Snap Inc.|
|Exposed: The secret powerhouse processing millions in global fraud|
|How Lester Holt is getting ready for Monday's debate|